Molecular basis for negative regulation of the glucagon receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 36, 2012, Pages 14393-14398

  Koth, Christopher M ^a   Murray, Jeremy M ^a   Mukund, Susmith ^a   Madjidi, Azadeh ^a   Minn, Alexandra ^a   Clarke, Holly J ^a   Wong, Terence ^a   Chiang, Vicki ^a   Luis, Elizabeth ^a   Estevez, Alberto ^a   Rondon, Jesus ^a   Zhang, Yingnan ^a   Hötzel, Isidro ^a   Allan, Bernard B ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GLUCAGON; GLUCAGON RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; MUTANT PROTEIN;

ARTICLE; CHEMICAL ANALYSIS; COMPLEX FORMATION; CRYSTAL STRUCTURE; HORMONE ACTION; HORMONE BINDING; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR BLOCKING;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; CHROMATOGRAPHY, AFFINITY; CRYSTALLOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUCAGON;

EID: 84865994337     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1206734109     Document Type: Article

References (36)

1. Jelinek LJ, et al. (1993) Expression cloning and signaling properties of the rat glucagon receptor. Science 259:1614-1616. (Pubitemid 23114641)
2. Unger RH, Cherrington AD (2012) Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover. J Clin Invest 122:4-12.
3. Dallas-Yang Q, et al. (2004) Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists. Eur J Pharmacol 501:225-234. (Pubitemid 39298956)
4. Unson CG, Andreu D, Gurzenda EM, Merrifield RB (1987) Synthetic peptide antagonists of glucagon. Proc Natl Acad Sci USA 84:4083-4087. (Pubitemid 17090879)
5. Petersen KF, Sullivan JT (2001) Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia 44: 2018-2024. (Pubitemid 33124047)
6. Sloop KW, et al. (2004) Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J Clin Invest 113: 1571-1581. (Pubitemid 39071680)
7. Gu W, et al. (2009) Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia. J Pharmacol Exp Ther 331:871-881.
8. Yan H, et al. (2009) Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys. J Pharmacol Exp Ther 329:102-111.
9. Hager J, et al. (1995) A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet 9:299-304.
10. Zhou C, Dhall D, Nissen NN, Chen CR, Yu R (2009) Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor. Pancreas 38:941-946.
11. Unson CG, et al. (1996) Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding. Proc Natl Acad Sci USA 93:310-315. (Pubitemid 26038149)
12. Runge S, Wulff BS, Madsen K, Bräuner-Osborne H, Knudsen LB (2003) Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity. Br J Pharmacol 138:787-794. (Pubitemid 36390634)
13. Dong M, Pinon DI, Cox RF, Miller LJ (2004) Importance of the amino terminus in secretin family G protein-coupled receptors. Intrinsic photoaffinity labeling establishes initial docking constraints for the calcitonin receptor. J Biol Chem 279:1167-1175. (Pubitemid 38082639)
14. Parthier C, Reedtz-Runge S, Rudolph R, Stubbs MT (2009) Passing the baton in class B GPCRs: Peptide hormone activation via helix induction? Trends Biochem Sci 34: 303-310.
15. Rasmussen SG, et al. (2011) Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature 469:175-180.
16. Grace CR, et al. (2004) NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc Natl Acad Sci USA 101:12836-12841. (Pubitemid 39167545)
17. Pioszak AA, Parker NR, Suino-Powell K, Xu HE (2008) Molecular recognition of corticotropin- releasing factor by its G-protein-coupled receptor CRFR1. J Biol Chem 283: 32900-32912.
18. Pioszak AA, Xu HE (2008) Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci USA 105:5034-5039. (Pubitemid 351738505)
19. Runge S, Thøgersen H, Madsen K, Lau J, Rudolph R (2008) Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283: 11340-11347.
20. Underwood CR, et al. (2010) Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. J Biol Chem 285:723-730.
21. Sun C, et al. (2007) Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS. Proc Natl Acad Sci USA 104:7875-7880. (Pubitemid 47185844)
22. Kumar S, Pioszak A, Zhang C, Swaminathan K, Xu HE (2011) Crystal structure of the PAC1R extracellular domain unifies a consensus fold for hormone recognition by class B G-protein coupled receptors. PLoS ONE 6:e19682.
23. ter Haar E, et al. (2010) Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18:1083-1093.
24. Carruthers CJ, Unson CG, Kim HN, Sakmar TP (1994) Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding. J Biol Chem 269:29321-29328.
25. Prévost M, et al. (2010) Mutational and cysteine scanning analysis of the glucagon receptor N-terminal domain. J Biol Chem 285:30951-30958.
26. Sasaki K, Dockerill S, Adamiak DA, Tickle IJ, Blundell T (1975) X-ray analysis of glucagon and its relationship to receptor binding. Nature 257:751-757.
27. Day JW, et al. (2011) Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action. J Pept Sci 17:218-225.
28. Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307. (Pubitemid 23242583)
29. Strange PG (2002) Mechanisms of inverse agonism at G-protein-coupled receptors. Trends Pharmacol Sci 23:89-95.
30. Lin SC, et al. (1993) Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364:208-213.
31. Godfrey P, et al. (1993) GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227-232. (Pubitemid 23205169)
32. Barwell J, Conner A, Poyner DR (2011) Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function. Biochim Biophys Acta 1813:1906-1916.
33. Rosenbaum DM, Rasmussen SG, Kobilka BK (2009) The structure and function of G-protein- coupled receptors. Nature 459:356-363.
34. Ballesteros JA, et al. (2001) Activation of the β-2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276:29171-29177.
35. Pin JP, et al. (2004) The activation mechanism of class-C G-protein coupled receptors. Biol Cell 96:335-342.
36. Hanson MA, et al. (2012) Crystal structure of a lipid G protein-coupled receptor. Science 335:851- 855.